ERIN RUSSELL: Open Payments
NPI 1730591744 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,977 in 127 payments from 19 companies in 2025. Trend: 2023 $1,712 · 2024 $2,734 · 2025 $1,977
Food & beverage: $1,903Education: $74
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 8 | $241 |
| Arcutis Biotherapeutics, Inc. | 33 | $236 |
| Regeneron Healthcare Solutions, Inc. | 11 | $170 |
| LEO Pharma Inc. | 9 | $167 |
| ABBVIE INC. | 15 | $162 |
| Incyte Corporation | 13 | $153 |
| Journey Medical Corporation | 3 | $130 |
| GENZYME CORPORATION | 5 | $124 |
| Janssen Biotech, Inc. | 3 | $113 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $92 |
Products named: DUPIXENT, NEMLUVIO, Zoryve, OPZELURA, SKYRIZI, ADBRY, TREMFYA, OTEZLA.
Industry payments across TX — which companies pay providers there.
